Heart Failure Management

Treatment of heart failure focuses on correcting the underlying pathology that is causing the syndrome and improving the efficiency of the heart in pumping blood around the body. Treatment includes:

Addressing any reversible causes of heart failure such as anemia, infection, excessive alcohol abuse, vitamin deficiency, overactive thyroid, high blood pressure and arrhythmia. Treating each of these individual factors reduces the heart's workload.

Lifestyle modifications may be made to help reduce and prevent the worsening of symptoms. Some of these include:

  • Complete cessation of smoking
  • Eating a healthy, balanced diet
  • Reducing salt intake
  • Water intake may be regulated on an individual basis
  • Reducing or stopping alcohol consumption
  • Engaging in regular exercise, as advised

If the onset of heart failure is sudden or acute, the immediate aim of therapy is to increase oxygen perfusion to various important organs such as the brain and kidneys. Medical staff ensure the patient is breathing and that blood is circulating. Therapies that may be immediately administered include furosemide, dilators such as nitroglycerin and sometimes non-invasive positive pressure ventilation (NIPPV).

In the case of long-term or chronic heart failure, treatment is aimed at preventing secondary acute attacks of heart failure and reducing symptoms. Examples of drugs that may be used include oral diuretics, ACE inhibitors, angiotensin receptor blockers, aldosterone receptor antagonists, beta-blockers and blood vessel dilators. A cardiac defibrillator may be needed in severe cases.

Some of the medications used for heart failure include:

  • Agents that raise the contractility or force of contraction of the heart such as digoxin. This drug is suitable only for some patients and it needs to be carefully administered and its effects closely monitored.
  • For acute heart failure, high efficacy diuretics may be used to reduce edema and ease the failure. Examples include furosemide and bumetanide. For chronic heart failure, furosemide or other drugs such as hydrochlorthiazide may be prescribed.
  • Angiotensin-converting enzyme (ACE) inhibitors reduce blood pressure, dilate blood vessels and also prevent the remodelling or enlargement of the heart seen in heart failure. Drugs in this class include enalapril, captopril and lisinopril.
  • Angiotensin receptor blockers act in a similar way to ACE inhibitors. Drugs of this class include losartan, valsartan and candesartan.
  • Aldosterone antagonists such as spironolactone.
  • Beta-blockers are useful in individuals with systolic dysfunction and examples include metoprolon, bisoprolol, nebivolol and carvedilol.
  • Blood vessel dilators help blood vessels to dilate and reduce the pressure against which the heart has to pump. Examples include hydralazine and nitrate.
  • Heart rhythm normalisers such as ivabradine.
  • Anticoagulants such as warfarin prevent the blood coagulating and reduce the risk of stroke and heart attack.
  • Antiplatelet medications such as aspirin and clopidogrel decrease the aggregation of blood platelets, therefore reducing complications such as stroke and heart attack.

Devices used in heart failure include:

  • Cardiac pacemakers that monitor the heart rate and if the rate becomes too slow, the pacemaker triggers pulses that hasten the heartbeat.
  • Cardiac resynchronisation therapy is another form of pacemaker therapy used to treat patients whose left and right heart chambers are not beating in unison.
  • Implantable cardioverter defibrillators are used to correct an abnormal heart rhythm called ventricular tachycardia (rapid but regular beating in lower heart chamber) and ventricular fibrillation (irregular and disorganized heart beat).

In the advanced stages of heart failure, surgery or transplantation may be required. Heart valve surgery can correct some types of heart failure and other types may require coronary bypass surgery.

Sources

  1. http://www.nhs.uk/Conditions/Heart-failure/Pages/Introduction.aspx
  2. https://www.heart.org/
  3. https://www.sign.ac.uk/
  4. http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300315.pdf
  5. https://healthy.kaiserpermanente.org/washington/front-door
  6. https://medlineplus.gov/

Further Reading

Last Updated: Jul 8, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 08). Heart Failure Management. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/health/Heart-Failure-Management.aspx.

  • MLA

    Mandal, Ananya. "Heart Failure Management". News-Medical. 31 October 2024. <https://www.news-medical.net/health/Heart-Failure-Management.aspx>.

  • Chicago

    Mandal, Ananya. "Heart Failure Management". News-Medical. https://www.news-medical.net/health/Heart-Failure-Management.aspx. (accessed October 31, 2024).

  • Harvard

    Mandal, Ananya. 2023. Heart Failure Management. News-Medical, viewed 31 October 2024, https://www.news-medical.net/health/Heart-Failure-Management.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Dietary inflammation linked to higher mortality risk in coronary heart disease patients